EFL042
Join host Chase Hendrickson, MD, from Vanderbilt University Medical Center, in a discussion about a recent article in The Journal of Clinical Endocrinology & Metabolism with Steven D. Wittlin, MD, from the University of Rochester Medical Center and guest expert Zhenqi Liu, MD, from the University of Virginia. The article featured this month, by Ingersen et al, was first published online in JCEM in June: “Effects of Aerobic Training and Semaglutide Treatment on Pancreatic β-Cell Secretory Function in Patients With Type 2 Diabetes.”
Meet the Speakers
Zhenqi Liu, MD, serves as chief of the Division of Endocrinology and Metabolism at the University of Virginia. He obtained his medical training at Hunan Medical University in China, received postdoctoral research training at Yale University and University of Virginia, and completed medicine residency at Washington Hospital Center and clinical endocrinology fellowship at University of Virginia. As an academic endocrinologist, Dr. Liu has published extensively on insulin action and diabetes. His clinical expertise includes general endocrinology, diabetes, and thyroid disorders, and his laboratory studies insulin action in health and diabetes, with a primary focus on the regulation of insulin action in the vasculature and its relation to insulin’s metabolic action and the cardiovascular complications of diabetes.
Steven Wittlin, MD, received his medical degree from Sackler School of Medicine, Tel Aviv University, and completed his residency, including serving as chief resident, at Booth Memorial Medical Center in New York. Dr. Wittlin completed his fellowship at New York University. He is a past Chief of Endocrinology and Assistant Chairman of Medicine at Booth Memorial Medical Center. Currently, Dr. Wittlin has been Professor of Medicine at the University of Rochester School of Medicine and Dentistry for more than 25 years. There he also serves as Director of Diabetes Services and Clinical Director of the Endocrine-Metabolism Division at the University of Rochester Medical Center. Dr. Wittlin’s research interests include diabetes, diabetes technology, and innovative treatments for diabetes. He has published numerous peer-reviewed articles and book chapters and received several teaching awards.
Resources